Greater Glasgow and Clyde Medicines
Key to symbols The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP The medicine should only be used and prescribed by a specialist Indicates the preferred choice within a class or group of medicines
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
9.6. Vitamins

9.6.4. Vitamin D

Preferred List
Specialist and GP
ALFACALCIDOL

Restrictions:

Restricted to specialist initiation.

Prescribing Notes:

Not suitable for treatment of vitamin D deficiency.

BNF Link

CALCIUM AND VITAMIN D (tablets, chewable tablets, effervescent tablets)

Prescribing Notes:

The current preferred calcium and vitamin D preparations in Acute Services and Primary Care are 

  • Accrete D3 One A Day chewable tablets (once daily) is first-line preparation
  • Accrete D3 film-coated tablets (twice daily) is second-line preparation for patients who do not tolerate the first-line preparation. Not suitable for patients with peanut or soybean allergy, and patients requiring a gelatin free preparation.
  • Adcal D3 Dissolve effervescent tablets (twice daily) preparation of choice for patients with swallowing difficulties or who have enteral tubes. 
  • Adcal D3 chewable tablets are available for oncology patients to reflect oncology protocols. Not suitable for patients with peanut or soybean allergy, and patients requiring a gelatin free preparation.

 

Please note: Calcium and vitamin D preparations may vary in strength, dosage and frequency.

BNF Link

Total Formulary
CALCIUM AND VITAMIN D (sachets, caplets)

Restrictions:

These formulations of calcium and vitamin D are restricted to use when Preferred List formulations are not tolerated.

Prescribing Notes:

Calcium and vitamin D tablets, chewable tablets and effervescent tablets are the preferred formulations (see Preferred List). 

Please note: Calcium and vitamin D preparations may vary in strength, dosage and frequency

BNF Link

CALCITRIOL

Restrictions:

Not approved for use in osteoporosis.

Prescribing Notes:

excluding Calcijex® preparation.

BNF Link

COLECALCIFEROL (VITAMIN D)

Restrictions:

Excludes Fultium D3 3,200 unit strength. Invita D3 oral ampoules are restricted to use only when other oral vitamin D preparations are not suitable.

Prescribing Notes:

For NHSGGC guidance on when to measure vitamin D levels and the subsequent management of vitamin D deficiency and insufficiency click here.  Also see the Prescribing Resources page for further useful documents.

Vitamin D supplementation usually falls into two broad categories, low dose supplementation and high dose supplementation.  Low dose is considered to be doses of 1,000 units daily or less and is used most often for supplementation in insufficiency states. High dose vitamin D is considered to be doses in excess of 20,000 units per week.  High dose vitamin D is more likely to be used in deficiency states leading to morbidity.

BNF Link